Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Ken Takanashi currently holds 5,729,003 shares of Satsuma Pharmaceuticals, Inc. (STSA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Ken Takanashi has been a net buyer of STSA stock. They have purchased $25.6M and sold $42.6K worth of shares.
Ken Takanashi's most recent insider trade was on Aug 11, 2025, when they sold 12,700 shares at $0.00 per share.
Ken Takanashi serves as Executive at Satsuma Pharmaceuticals, Inc. (STSA). They have executed 10 insider transactions totaling $25.6M over their tenure at the company.
Ken Takanashi holds the position of Executive at Satsuma Pharmaceuticals, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 11 years and currently hold a stake valued at $0.
Ken Takanashi has shown a buying trading pattern, with $25.6M in total purchases and $42.6K in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Ken Takanashi was on Jun 6, 2023, when they purchased $20.1M worth of STSA shares. This transaction involved 22,053,581 shares at $0.91 per share.
Ken Takanashi currently owns 5,729,003 shares of Satsuma Pharmaceuticals, Inc. (STSA), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Ken Takanashi's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Ken Takanashi has 10 Form 4 filings on record as an insider at Satsuma Pharmaceuticals, Inc..
Set alerts for Ken Takanashi and 40,000+ other insiders.